247 related articles for article (PubMed ID: 21326242)
1. Different miRNA signatures of oral and pharyngeal squamous cell carcinomas: a prospective translational study.
Lajer CB; Nielsen FC; Friis-Hansen L; Norrild B; Borup R; Garnæs E; Rossing M; Specht L; Therkildsen MH; Nauntofte B; Dabelsteen S; von Buchwald C
Br J Cancer; 2011 Mar; 104(5):830-40. PubMed ID: 21326242
[TBL] [Abstract][Full Text] [Related]
2. Genome-wide study of salivary miRNAs identifies miR-423-5p as promising diagnostic and prognostic biomarker in oral squamous cell carcinoma.
Romani C; Salviato E; Paderno A; Zanotti L; Ravaggi A; Deganello A; Berretti G; Gualtieri T; Marchini S; D'Incalci M; Mattavelli D; Piazza C; Bossi P; Romualdi C; Nicolai P; Bignotti E
Theranostics; 2021; 11(6):2987-2999. PubMed ID: 33456584
[TBL] [Abstract][Full Text] [Related]
3. Salivary extracellular vesicle-associated miRNAs as potential biomarkers in oral squamous cell carcinoma.
Gai C; Camussi F; Broccoletti R; Gambino A; Cabras M; Molinaro L; Carossa S; Camussi G; Arduino PG
BMC Cancer; 2018 Apr; 18(1):439. PubMed ID: 29669525
[TBL] [Abstract][Full Text] [Related]
4. Oral squamous cell carcinoma: microRNA expression profiling and integrative analyses for elucidation of tumourigenesis mechanism.
Manikandan M; Deva Magendhra Rao AK; Arunkumar G; Manickavasagam M; Rajkumar KS; Rajaraman R; Munirajan AK
Mol Cancer; 2016 Apr; 15():28. PubMed ID: 27056547
[TBL] [Abstract][Full Text] [Related]
5. Salivary exosomal miR-24-3p serves as a potential detective biomarker for oral squamous cell carcinoma screening.
He L; Ping F; Fan Z; Zhang C; Deng M; Cheng B; Xia J
Biomed Pharmacother; 2020 Jan; 121():109553. PubMed ID: 31704611
[TBL] [Abstract][Full Text] [Related]
6. Genetic variants in microRNA-146a (C>G) and microRNA-1269b (G>C) are associated with the decreased risk of oral premalignant lesions, oral cancer, and pharyngeal cancer.
Chen HC; Tseng YK; Chi CC; Chen YH; Yang CM; Huang SJ; Lee YC; Liou HH; Tsai KW; Ger LP
Arch Oral Biol; 2016 Dec; 72():21-32. PubMed ID: 27525378
[TBL] [Abstract][Full Text] [Related]
7. Comparative genomic analysis of oral versus laryngeal and pharyngeal cancer.
Vossen DM; Verhagen CVM; Verheij M; Wessels LFA; Vens C; van den Brekel MWM
Oral Oncol; 2018 Jun; 81():35-44. PubMed ID: 29884412
[TBL] [Abstract][Full Text] [Related]
8. MicroRNA-based classifiers for diagnosis of oral cavity squamous cell carcinoma in tissue and plasma.
Pedersen NJ; Jensen DH; Lelkaitis G; Kiss K; Charabi BW; Ullum H; Specht L; Schmidt AY; Nielsen FC; von Buchwald C
Oral Oncol; 2018 Aug; 83():46-52. PubMed ID: 30098778
[TBL] [Abstract][Full Text] [Related]
9. Circulating miRNAs as biomarkers for oral squamous cell carcinoma recurrence in operated patients.
Yan Y; Wang X; Venø MT; Bakholdt V; Sørensen JA; Krogdahl A; Sun Z; Gao S; Kjems J
Oncotarget; 2017 Jan; 8(5):8206-8214. PubMed ID: 28030794
[TBL] [Abstract][Full Text] [Related]
10. MicroRNA alterations and associated aberrant DNA methylation patterns across multiple sample types in oral squamous cell carcinoma.
Wiklund ED; Gao S; Hulf T; Sibbritt T; Nair S; Costea DE; Villadsen SB; Bakholdt V; Bramsen JB; Sørensen JA; Krogdahl A; Clark SJ; Kjems J
PLoS One; 2011; 6(11):e27840. PubMed ID: 22132151
[TBL] [Abstract][Full Text] [Related]
11. MiRNA expression profiling and emergence of new prognostic signature for oral squamous cell carcinoma.
Rajan C; Roshan VGD; Khan I; Manasa VG; Himal I; Kattoor J; Thomas S; Kondaiah P; Kannan S
Sci Rep; 2021 Mar; 11(1):7298. PubMed ID: 33790326
[TBL] [Abstract][Full Text] [Related]
12. Exploration of tumor-suppressive microRNAs silenced by DNA hypermethylation in oral cancer.
Kozaki K; Imoto I; Mogi S; Omura K; Inazawa J
Cancer Res; 2008 Apr; 68(7):2094-105. PubMed ID: 18381414
[TBL] [Abstract][Full Text] [Related]
13. miRNA genetic variants: As potential diagnostic biomarkers for oral cancer.
Tandon D; Dewangan J; Srivastava S; Garg VK; Rath SK
Pathol Res Pract; 2018 Feb; 214(2):281-289. PubMed ID: 29103762
[TBL] [Abstract][Full Text] [Related]
14. Altered levels of miR-21, miR-125b-2*, miR-138, miR-155, miR-184, and miR-205 in oral squamous cell carcinoma and association with clinicopathological characteristics.
Manikandan M; Deva Magendhra Rao AK; Rajkumar KS; Rajaraman R; Munirajan AK
J Oral Pathol Med; 2015 Nov; 44(10):792-800. PubMed ID: 25482863
[TBL] [Abstract][Full Text] [Related]
15. MicroRNA expression as predictor of local recurrence risk in oral squamous cell carcinoma.
Ganci F; Sacconi A; Manciocco V; Sperduti I; Battaglia P; Covello R; Muti P; Strano S; Spriano G; Fontemaggi G; Blandino G
Head Neck; 2016 Apr; 38 Suppl 1():E189-97. PubMed ID: 25532855
[TBL] [Abstract][Full Text] [Related]
16. miRNAs expression of oral squamous cell carcinoma patients: Validation of two putative biomarkers.
Chamorro Petronacci CM; Pérez-Sayáns M; Padín Iruegas ME; Suárez Peñaranda JM; Lorenzo Pouso AI; Blanco Carrión A; García García A
Medicine (Baltimore); 2019 Mar; 98(13):e14922. PubMed ID: 30921188
[TBL] [Abstract][Full Text] [Related]
17. Interplay between cancer cells and M2 macrophages is necessary for miR-550a-3-5p down-regulation-mediated HPV-positive OSCC progression.
Cao MX; Zhang WL; Yu XH; Wu JS; Qiao XW; Huang MC; Wang K; Wu JB; Tang YJ; Jiang J; Liang XH; Tang YL
J Exp Clin Cancer Res; 2020 Jun; 39(1):102. PubMed ID: 32493454
[TBL] [Abstract][Full Text] [Related]
18. Complex integrated analysis of lncRNAs-miRNAs-mRNAs in oral squamous cell carcinoma.
Li S; Chen X; Liu X; Yu Y; Pan H; Haak R; Schmidt J; Ziebolz D; Schmalz G
Oral Oncol; 2017 Oct; 73():1-9. PubMed ID: 28939059
[TBL] [Abstract][Full Text] [Related]
19. Expression of stem cell-regulating miRNAs in oral cavity and oropharynx squamous cell carcinoma.
Brito BL; Lourenço SV; Damascena AS; Kowalski LP; Soares FA; Coutinho-Camillo CM
J Oral Pathol Med; 2016 Oct; 45(9):647-654. PubMed ID: 26841253
[TBL] [Abstract][Full Text] [Related]
20. Differentially expressed microRNAs, including a large microRNA cluster on chromosome 24, are associated with equine sarcoid and squamous cell carcinoma.
Bogedale K; Jagannathan V; Gerber V; Unger L
Vet Comp Oncol; 2019 Jun; 17(2):155-164. PubMed ID: 30684296
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
